• Mashup Score: 0

    Topic: Drug Development for Ovarian Cancer: Challenges and SuccessesUrsula Matulonis, MD is Chief and Director of the Division of Gynecologic Oncology at the…

    Tweet Tweets with this article
    • I enjoyed hosting @DanaFarber’s Ursula Matulonis as she shared insights on #DrugDevelopment for #OvarianCancer. Watch: https://t.co/QNWF6kOxcX Mark your calendar for our 10/10 Breakthroughs in Cancer seminar with @JenniferGrandis of @UCSF https://t.co/691xVm2mDc

  • Mashup Score: 4

    American Association for Cancer Research (AACR), American Statistical Association (ASA), and U.S. Food and Drug Administration (FDA) are partnering to host a workshop on July 18, 2023, at the Bethesda Marriott Pooks Hill hotel in North Bethesda, MD to discuss the use of overall survival (OS) and other endpoints in oncology clinical trials.

    Tweet Tweets with this article
    • Did you miss the 7/18/2023 FDA-AACR-ASA Workshop on Overall Survival in #Oncology #ClinicalTrials? Slides & recording are now available: https://t.co/YVCbDPJdfS #AACRSciencePolicy #regulatory #biostats #drugdevelopment #OncTwitter https://t.co/jIfcvwLscV

  • Mashup Score: 1
    How to Apply | NExT - 9 month(s) ago

    Last Updated: 01/11/23 Overview The NCI Experimental Therapeutics (NExT) pipeline is designed to assist translation to the clinic of novel therapeutic interventions, either synthetic, natural product, or biologic, arising from academic, private, or government entities. NExT is not a grant mechanism. Approved proposals gain access to drug discovery resources and development…

    Tweet Tweets with this article
    • The Experimental Therapeutics (NExT) Program works to advance clinical practice and improve therapies for people with cancer by supporting promising new #DrugDiscovery and #DrugDevelopment projects. The application cycle opens on September 15. https://t.co/x6kX1dFGEG https://t.co/TAjpzmc9ZY

  • Mashup Score: 0

    American Association for Cancer Research (AACR), American Statistical Association (ASA), and U.S. Food and Drug Administration (FDA) are partnering to host a workshop on July 18, 2023, at the Bethesda Marriott Pooks Hill hotel in North Bethesda, MD to discuss the use of overall survival (OS) and other endpoints in oncology clinical trials.

    Tweet Tweets with this article
    • Starting now, #OncTwitter! Looking forward to joining the panel for session 1 discussing design of #cancer #clinicaltrials. Streaming Tues 7/18/23 8a-5p ET: https://t.co/4hVIiICo7M. @FDAOncology @AACR @AmstatNews #regulatory #drugdevelopment #MedTwitter #AACRSciencePolicy https://t.co/WmuAj4xV7A https://t.co/eChudvAPI9

  • Mashup Score: 0

    Recorded and edited interviews for the “Patient Perspectives: Today’s Unmet Need” session at the 2023 Amyloidosis Forum meeting.

    Tweet Tweets with this article
    • Researchers, life science companies, & other #ATTR #amyloidosis HCPs: What's really important to patients and caregivers? For the #AmyloidosisForum we worked with @MathewMaurer to ask patients how the next phase of #drugdevelopment will impact their lives https://t.co/Jp151XzO7l